JCR Successfully Develops Blood-Brain Barrier-Passing Technology; First Application to Be Drug for Hunter Syndrome

JCR Pharmaceuticals announced on April 14 that it has succeeded in developing “J-Brain Cargo”, a technology that enables drugs to pass through the blood-brain barrier (BBB). J-Brain Cargo is a proprietary technology that enables the delivery of target substances through...read more